Abstract Library

#2700 Pancreatic Neuroendocrine Neoplasms and Liver Metastases: When Size Matters

Introduction: Small non-functioning pNENs are low grade indolent tumors, however distant metastases have also been documented in this subset of patients

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Monteleone M, Rossi R, Altomare M, Prinzi N, Cattaneo L,

Keywords: Pancreatic neuroendocrine neoplasia, Liver metastases,

#1630 The Positive Expression of PD-L1/PD-1 in Gastroenteropancreatic Neuroendocrine Neoplasias Correlates with Prognosis

Introduction: The incidence of Neuroendocrine Neoplasias (NENs) is increasing and their pathological characteristics, varied between races. However, the epidemiology of GEP-NENs in Chinese patients remains poorly characterized especially for the expression of important immune checkpoint protein PD1 and PD-L1.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Yinying W, Chuying W,

Keywords: gastroenteropancreatic neuroendocrine neoplasias, PD-L1, PD-1, immunohistochemistry, prognosis,

#1553 A Novel In Vitro Model of a Highly Proliferative Pancreatic Neuroendocrine Neoplasia

Introduction: Transformation of well-differentiated neuroendocrine tumors into highly proliferative neuroendocrine neoplasms is a rare, but clinical relevant phenomenon. So far, it is unclear whether these tumors should be treated in analogy to neuroendocrine tumors or as bona fide neuroendocrine carcinoma.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Schrader J

Authors: Behrang Y, Benten D, Erbes J, Eggers C, Fahl M,

Keywords: cell line,

#1524 Is mTOR Pathway Activity a Good Predictor for Everolimus Therapy? A Pilot Study to Build Up a Phase II Trial in Pancreatic Neuroendocrine Neoplasias (pNENs)

Introduction: Everolimus (EVE) is an approved treatment for progressive well-differentiated pNENs and usually induces stable disease. Until now, there is no reliable biomarker for the response to EVE.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Lock A

Authors: Lock A, Wirtz R, Kaemmerer D, Haugvik S, Kure E,

Keywords: PREDICT-Study, everolimus, pNEN, gene signature, predictive marker,

#1313 C-Reactive Protein As a New Prognostic Factor for Overall Survival in Patients with Pancreatic Neuroendocrine Neoplasia

Introduction: For many cancer entities, inflammation has been shown to play an important role in pathogenesis and progression.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Fendrich V

Authors: Fendrich V, Wiese D, Kampe K, Heverhagen A, Waldmann J,

Keywords: CRP, prognosis, pNEN, survival,